{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:32:49Z","timestamp":1789731169695,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373871"],"award-info":[{"award-number":["82373871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61883-y","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T18:00:41Z","timestamp":1753380041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["UCP2 inhibition eliminates pancreatic \u03b2 cell autoinflammation in T2DM with islet-mitochondrial sequential targeting nanomedicines"],"prefix":"10.1038","volume":"16","author":[{"given":"Zerun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0570-5961","authenticated-orcid":false,"given":"Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-8963","authenticated-orcid":false,"given":"Kelong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"61883_CR1","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","volume":"11","author":"S Kaptoge","year":"2023","unstructured":"Kaptoge, S. et al. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diab. Endocrinol. 11, 731\u2013742 (2023).","journal-title":"Lancet Diab. Endocrinol."},{"key":"61883_CR2","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor, R., Al-Mrabeh, A. & Sattar, N. Understanding the mechanisms of reversal of type 2 diabetes [J]. Lancet Diab. Endocrinol. 7, 726\u2013736 (2019).","journal-title":"Lancet Diab. Endocrinol."},{"key":"61883_CR3","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202406180","volume":"177","author":"AL Crawford","year":"2024","unstructured":"Crawford, A. L. & Laiteerapong, N. Type 2 diabetes. Ann. Intern Med. 177, ITC81\u2013ITC96 (2024).","journal-title":"Ann. Intern Med."},{"key":"61883_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/JCI88877","volume":"127","author":"K Eguchi","year":"2017","unstructured":"Eguchi, K. & Nagai, R. Islet inflammation in type 2 diabetes and physiology. J. Clin. Investig. 127, 14\u201323 (2017).","journal-title":"J. Clin. Investig."},{"key":"61883_CR5","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1056\/NEJMoa065213","volume":"356","author":"CM Larsen","year":"2007","unstructured":"Larsen, C. M. et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356, 1517\u20131526 (2007).","journal-title":"N. Engl. J. Med."},{"key":"61883_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/mt.2015.227","volume":"24","author":"C Cavelti-Weder","year":"2016","unstructured":"Cavelti-Weder, C. et al. Development of an Interleukin-1\u03b2 Vaccine in Patients with Type 2 Diabetes. Mol. Ther. 24, 1003\u20131012 (2016).","journal-title":"Mol. Ther."},{"key":"61883_CR7","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.2337\/dc12-1835","volume":"36","author":"J Sloan-Lancaster","year":"2013","unstructured":"Sloan-Lancaster, J. et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1\u03b2 antibody, in patients with type 2 Diabetes. Diab. Care 36, 2239\u20132246 (2013).","journal-title":"Diab. Care"},{"key":"61883_CR8","unstructured":"University Hospital B, Switzerland. IL-1-receptor antagonist during cephalic phase of insulin secretion in health and Type 2 Diabetes (Cephalira) [Z.]."},{"key":"61883_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41574-023-00898-1","volume":"20","author":"G Xourafa","year":"2024","unstructured":"Xourafa, G., Korbmacher, M. & Roden, M. Inter-organ crosstalk during development and progression of type 2 diabetes mellitus. Nat. Rev. Endocrinol. 20, 27\u201349 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"61883_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98\u2013107 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"61883_CR11","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1172\/JCI92172","volume":"127","author":"K Maedler","year":"2017","unstructured":"Maedler, K. et al. Glucose-induced \u03b2 cell production of IL-1\u03b2 contributes to glucotoxicity in human pancreatic islets. J. Clin. Investig. 127, 1589 (2017).","journal-title":"J. Clin. Investig."},{"key":"61883_CR12","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.celrep.2018.01.063","volume":"22","author":"M B\u00f6ni-Schnetzler","year":"2018","unstructured":"B\u00f6ni-Schnetzler, M. et al. \u03b2 cell-specific deletion of the IL-1 receptor antagonist impairs \u03b2 cell proliferation and insulin secretion. Cell Rep. 22, 1774\u20131786 (2018).","journal-title":"Cell Rep."},{"key":"61883_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","volume":"19","author":"MY Donath","year":"2019","unstructured":"Donath, M. Y., Dinarello, C. A. & Mandrup-Poulsen, T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat. Rev. Immunol. 19, 734\u2013746 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"61883_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cmet.2022.06.003","volume":"34","author":"MJ Merrins","year":"2022","unstructured":"Merrins, M. J. et al. Metabolic cycles and signals for insulin secretion. Cell Metab. 34, 947\u2013968 (2022).","journal-title":"Cell Metab."},{"key":"61883_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","volume":"30","author":"E Vringer","year":"2023","unstructured":"Vringer, E. & Tait, S. W. G. Mitochondria and cell death-associated inflammation. Cell Death Differ. 30, 304\u2013312 (2023).","journal-title":"Cell Death Differ."},{"key":"61883_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3733","volume":"40","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Mitochondrial damage-associated molecular patterns: a new insight into metabolic inflammation in type 2 diabetes mellitus. Diab.-Metab. Res. Rev. 40, e3733 (2024).","journal-title":"Diab.-Metab. Res. Rev."},{"key":"61883_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.110890","volume":"518","author":"HQ Hu","year":"2020","unstructured":"Hu, H. Q. et al. The STING-IRF3 pathway is involved in lipotoxic injury of pancreatic \u03b2 cells in type 2 diabetes. Mol. Cell. Endocrinol. 518, 110890 (2020).","journal-title":"Mol. Cell. Endocrinol."},{"key":"61883_CR18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101848119","volume":"119","author":"JT Qiao","year":"2022","unstructured":"Qiao, J. T. et al. A distinct role of STING in regulating glucose homeostasis through insulin sensitivity and insulin secretion. Proc. Natl. Acad. Sci. USA 119, e2101848119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61883_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0092-8674(01)00389-0","volume":"105","author":"KS Polonsky","year":"2001","unstructured":"Polonsky, K. S. & Semenkovich, C. F. The pancreatic \u03b2 cell heats up: UCP2 and insulin secretion in diabetes. Cell 105, 705\u2013707 (2001).","journal-title":"Cell"},{"key":"61883_CR20","volume":"23","author":"YS Cho","year":"2022","unstructured":"Cho, Y. S. Genipin, an inhibitor of UCP2 as a promising new anticancer agent: a review of the literature. Int. J. Mol. Sci. 23, e13289 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"61883_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0092-8674(01)00378-6","volume":"105","author":"CY Zhang","year":"2001","unstructured":"Zhang, C. Y. et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, \u03b2 cell dysfunction, and type 2 diabetes. Cell 105, 745\u2013755 (2001).","journal-title":"Cell"},{"key":"61883_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47686-7","volume":"15","author":"J Lehrstrand","year":"2024","unstructured":"Lehrstrand, J. et al. Illuminating the complete \u00df-cell mass of the human pancreas- signifying a new view on the islets of Langerhans. Nat. Commun. 15, 3318 (2024).","journal-title":"Nat. Commun."},{"key":"61883_CR23","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.cmet.2023.06.018","volume":"35","author":"MA Atkinson","year":"2023","unstructured":"Atkinson, M. A. & Mirmira, R. G. The pathogenic \u201csymphony\u201cin type 1 diabetes: a disorder of the immune system, b cells, and exocrine pancreas. Cell Metab. 35, 1500\u20131518 (2023).","journal-title":"Cell Metab."},{"key":"61883_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1083\/jcb.100.2.418","volume":"100","author":"EL Bearer","year":"1985","unstructured":"Bearer, E. L. & Orci, L. Endothelial fenestral diaphragms: a quick-freeze, deep-etch study.  J. Cell Biol. 100, 418\u2013428 (1985).","journal-title":"J. Cell Biol."},{"key":"61883_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2006.04.010","volume":"3","author":"C-Y Zhang","year":"2006","unstructured":"Zhang, C.-Y. et al. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced \u03b2 cell dysfunction in isolated pancreatic islets. Cell Metab. 3, 417\u2013427 (2006).","journal-title":"Cell Metab."},{"key":"61883_CR26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct. Target. Ther. 8, 152 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61883_CR27","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1038\/s41596-021-00560-y","volume":"16","author":"NJ Hogrebe","year":"2021","unstructured":"Hogrebe, N. J. et al. Generation of insulin-producing pancreatic \u03b2 cells from multiple human stem cell lines. Nat. Protoc. 16, 4109\u20134143 (2021).","journal-title":"Nat. Protoc."},{"key":"61883_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s13287-020-01977-0","volume":"11","author":"II Aigha","year":"2020","unstructured":"Aigha, I. I. & Abdelalim, E. M. NKX6.1 transcription factor: a crucial regulator of pancreatic \u03b2 cell development, identity, and proliferation. Stem Cell Res Ther. 11, 459 (2020).","journal-title":"Stem Cell Res Ther."},{"key":"61883_CR29","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","volume":"53","author":"GC Weir","year":"2004","unstructured":"Weir, G. C. & Bonner-Weir, S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53, S16\u2013S21 (2004).","journal-title":"Diabetes"},{"key":"61883_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1293\/tox.22.133","volume":"22","author":"M Yamazaki","year":"2009","unstructured":"Yamazaki, M. et al. Segmentation of the pathophysiological stages of diabetic changes in the db\/db mouse. J. Toxicol. Pathol. 22, 133\u2013137 (2009).","journal-title":"J. Toxicol. Pathol."},{"key":"61883_CR31","doi-asserted-by":"publisher","first-page":"e82813","DOI":"10.1371\/journal.pone.0082813","volume":"8","author":"LS Dalb\u00f8ge","year":"2013","unstructured":"Dalb\u00f8ge, L. S. et al. Characterisation of age-dependent beta cell dynamics in the male db\/db mice. PLOS ONE 8, e82813 (2013).","journal-title":"PLOS ONE"},{"key":"61883_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/aps.2008.17","volume":"30","author":"S-Y Wu","year":"2009","unstructured":"Wu, S.-Y. et al. Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin. Acta Pharmacologica Sin. 30, 202\u2013208 (2009).","journal-title":"Acta Pharmacologica Sin."},{"key":"61883_CR33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.exger.2013.09.001","volume":"48","author":"L Guan","year":"2013","unstructured":"Guan, L. et al. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. Exp. Gerontol. 48, 1387\u20131394 (2013).","journal-title":"Exp. Gerontol."},{"key":"61883_CR34","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1091\/mbc.e12-12-0885","volume":"24","author":"G Verma","year":"2013","unstructured":"Verma, G., Bhatia, H. & Datta, M. JNK1\/2 regulates ER\u2013mitochondrial Ca2+ cross-talk during IL-1\u03b2\u2013mediated cell death in RINm5F and human primary \u03b2-cells. Mol. Biol. Cell 24, 2058\u20132071 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"61883_CR35","first-page":"111","volume":"27","author":"C Cao","year":"2022","unstructured":"Cao, C. et al. Inflammatory stimulation mediates nucleus pulposus cell necroptosis through mitochondrial function disfunction and oxidative stress pathway. FBL 27, 111 (2022).","journal-title":"FBL"},{"key":"61883_CR36","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","volume":"55","author":"H Xian","year":"2022","unstructured":"Xian, H. et al. Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity 55, 1370\u20131385.e8 (2022).","journal-title":"Immunity"},{"key":"61883_CR37","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","volume":"21","author":"A Decout","year":"2021","unstructured":"Decout, A. et al. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat. Rev. Immunol. 21, 548\u2013569 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"61883_CR38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.tcb.2018.02.009","volume":"28","author":"G Csord\u00e1s","year":"2018","unstructured":"Csord\u00e1s, G., Weaver, D. & Hajn\u00f3czky, G. Endoplasmic reticulum-mitochondrial contactology: structure and signaling functions. Trends Cell Biol. 28, 523\u2013540 (2018).","journal-title":"Trends Cell Biol."},{"key":"61883_CR39","doi-asserted-by":"crossref","unstructured":"Wang S., et al. Inhibiting mitochondrial damage for efficient treatment of cerebral ischemia-reperfusion injury through sequential targeting nanomedicine of neuronal mitochondria in affected brain tissue. 36, 2409529 (2024).","DOI":"10.1002\/adma.202409529"},{"key":"61883_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41574-021-00510-4","volume":"17","author":"J Yong","year":"2021","unstructured":"Yong, J. et al. Therapeutic opportunities for pancreatic \u03b2-cell ER stress in diabetes mellitus. Nat. Rev. Endocrinol. 17, 455\u2013467 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"61883_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aba9112","volume":"14","author":"E Ilegems","year":"2022","unstructured":"Ilegems, E. et al. HIF-1\u03b1 inhibitor PX-478 preserves pancreatic. cell function in diabetes. Sci. Transl. Med. 14, eaba9112 (2022).","journal-title":"Sci. Transl. Med."},{"key":"61883_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41392-022-01252-z","volume":"7","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy. Signal Transduct. Target. Ther. 7, 394 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"61883_CR43","doi-asserted-by":"publisher","first-page":"12196","DOI":"10.1073\/pnas.1708744114","volume":"114","author":"J Bai","year":"2017","unstructured":"Bai, J. et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc. Natl. Acad. Sci. USA 114, 12196\u201312201 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61883_CR44","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"NA Elsayed","year":"2024","unstructured":"Elsayed, N. A. et al. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diab. Care 47, S20\u2013S42 (2024).","journal-title":"Diab. Care"},{"key":"61883_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300880","volume":"10","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. Selenium nanodots (SENDs) as antioxidants and antioxidant-prodrugs to rescue islet beta cells in type 2 diabetes mellitus by restoring mitophagy and alleviating endoplasmic reticulum stress. Adv. Sci.10, e2300880 (2023).","journal-title":"Adv. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61883-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T23:06:20Z","timestamp":1757286380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61883-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61883"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61883-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6840"}}